–
Oramed Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
0.01
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.2
FY22:
−40.6
FY23:
−15.8
FY24:
−12.8
FY25:
−15.1
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−37.0
FY23:
–
FY24:
−7.63
FY25:
−12.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−37.7
FY23:
5.09
FY24:
−15.9
FY25:
75.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.0
FY22:
−36.6
FY23:
5.09
FY24:
−19.1
FY25:
64.1
All amounts in millions USD